A biomimetic antitumor nanovaccine based on biocompatible calcium pyrophosphate and tumor cell membrane antigens

Currently, the cancer immunotherapy has made great progress while antitumor vaccine attracts substantial attention. Still, the selection of adjuvants as well as antigens are always the most crucial issues for better vaccination. In this study, we proposed a biomimetic antitumor nanovaccine based on...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Minghui, Qin, Mengmeng, Song, Ge, Deng, Hailiang, Wang, Dakuan, Wang, Xueqing, Dai, Wenbing, He, Bing, Zhang, Hua, Zhang, Qiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Shenyang Pharmaceutical University 2021
Materias:
Original Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7878462/
https://www.ncbi.nlm.nih.gov/pubmed/33613733
http://dx.doi.org/10.1016/j.ajps.2020.06.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7878462/
https://www.ncbi.nlm.nih.gov/pubmed/33613733
http://dx.doi.org/10.1016/j.ajps.2020.06.006

Ejemplares similares